1.11.6 Intrinsic Apoptosis Definition

Intrinsic Apoptosis Definition is the precise characterization of the mitochondrial pathway of programmed cell death, triggered by internal cellular stress signals rather than by extracellular death ligands, and executed through mitochondrial outer membrane permeabilization, cytochrome c release, and activation of the initiator caspase-9. Intrinsic apoptosis is defined as the specific apoptotic route through which a cell integrates diverse internal stress signals, such as DNA damage, oncogene activation, endoplasmic reticulum stress, and growth factor deprivation, into a unified decision regarding cell survival or death, governed centrally by the relative balance of pro-apoptotic and anti-apoptotic BCL-2 family proteins.

Formally, intrinsic apoptosis is defined by its dependence on mitochondrial outer membrane permeabilization as the point of no return: once this event occurs, release of cytochrome c and other pro-apoptotic factors from the mitochondrial intermembrane space into the cytosol commits the cell irreversibly to the downstream caspase cascade and death.

Molecular Regulation by the BCL-2 Family

Pro-Apoptotic Effectors

BAX and BAK are pro-apoptotic effector proteins that, upon activation, oligomerize within the mitochondrial outer membrane to form pores directly responsible for its permeabilization, representing the immediate executors of the intrinsic pathway's decisive step.

Pro-Apoptotic BH3-Only Sensors

BH3-only proteins, such as BID, BIM, and PUMA, function as sensors of specific cellular stress signals and act either by directly activating BAX and BAK or by neutralizing anti-apoptotic BCL-2 family members, thereby transmitting diverse upstream stress signals into the core mitochondrial decision point.

Anti-Apoptotic Guardians

Anti-apoptotic proteins, including BCL-2, BCL-XL, and MCL-1, restrain BAX and BAK activity and sequester BH3-only proteins, maintaining mitochondrial membrane integrity under normal conditions; the overall commitment to intrinsic apoptosis is determined by the shifting balance among these three functional classes of BCL-2 family proteins.

Execution Sequence

Mitochondrial Outer Membrane Permeabilization

When pro-apoptotic signaling predominates, BAX and BAK oligomerize to permeabilize the mitochondrial outer membrane, an event considered the defining, committed step of the intrinsic pathway.

Cytochrome c Release and Apoptosome Formation

Released cytochrome c binds the adaptor protein APAF-1 in the cytosol, promoting its oligomerization into a heptameric structure known as the apoptosome, which recruits and activates initiator caspase-9.

Executioner Caspase Activation

Active caspase-9 cleaves and activates executioner caspases, principally caspase-3 and caspase-7, which carry out the proteolytic cleavage of cellular substrates responsible for the characteristic morphological features of apoptosis.

Triggers of Intrinsic Apoptosis

DNA Damage

Significant, unrepaired DNA damage activates the p53 tumor suppressor, which transcriptionally induces pro-apoptotic BH3-only proteins such as PUMA and NOXA, linking genomic integrity surveillance directly to the intrinsic apoptotic pathway.

Oncogenic Stress

Aberrant, excessive activation of oncogenic signaling pathways can trigger intrinsic apoptosis as a protective mechanism, functioning as a barrier against the survival of cells bearing potentially transforming genetic alterations.

Growth Factor and Survival Signal Withdrawal

Removal of growth factors or survival signals reduces expression or activity of anti-apoptotic BCL-2 family proteins, shifting the balance toward BAX/BAK activation and commitment to intrinsic apoptosis.

Relevance to Cancer Biology

Evasion of intrinsic apoptosis is one of the most consistently observed alterations across human cancers, commonly achieved through overexpression of anti-apoptotic BCL-2 family members, downregulation or mutation of pro-apoptotic effectors, or loss of p53 function, each of which shifts the mitochondrial balance toward survival despite the presence of DNA damage or oncogenic stress that would normally commit a cell to this pathway.